Home > Insider Trading > Filing (0001209191-19-055469)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Cl&Ao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-11-04	2,330	$86.52	37,333	No	4	M	Direct
Common Stock	Disposition	2019-11-04	1,730	$200.20	35,603	No	4	S	Direct
Common Stock	Disposition	2019-11-04	600	$201.37	35,003	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-11-04	2,330	$0.00	2,330	$86.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,650		2027-02-02	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $200.20 (range $199.81 to $200.52).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $201.37 (range $201.33 to $201.39).
The option vests in 16 quarterly installments from 02/03/2017.